胸外科医师学会评分差异导致行经导管主动脉瓣置换术患者的风险再分类。
Society of Thoracic Surgeons Score Variance Results in Risk Reclassification of Patients Undergoing Transcatheter Aortic Valve Replacement.
机构信息
MedStar Washington Hospital Center, Washington, DC2Cardiovascular and Pulmonary Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
MedStar Washington Hospital Center, Washington, DC.
出版信息
JAMA Cardiol. 2017 Apr 1;2(4):455-456. doi: 10.1001/jamacardio.2016.4132.
Abstract
This study compares the Society of Thoracic Surgeons scores of patients in 2008/2009 with their recalculated 2015 scores.
摘要
本研究比较了 2008/2009 年患者的胸外科医师学会评分与重新计算的 2015 年评分。
相似文献
1
Society of Thoracic Surgeons Score Variance Results in Risk Reclassification of Patients Undergoing Transcatheter Aortic Valve Replacement.胸外科医师学会评分差异导致行经导管主动脉瓣置换术患者的风险再分类。
JAMA Cardiol. 2017 Apr 1;2(4):455-456. doi: 10.1001/jamacardio.2016.4132.
2
Does a Higher Society of Thoracic Surgeons Score Predict Outcomes in Transfemoral and Alternative Access Transcatheter Aortic Valve Replacement?胸外科医师协会评分较高是否能预测经股动脉及其他入路经导管主动脉瓣置换术的预后？
Ann Thorac Surg. 2016 Aug;102(2):474-82. doi: 10.1016/j.athoracsur.2016.02.020. Epub 2016 May 19.
3
Sex-Based Differences in Outcomes With Transcatheter Aortic Valve Therapy: TVT Registry From 2011 to 2014.基于性别的经导管主动脉瓣治疗结果差异：2011 年至 2014 年的 TVT 注册研究。
J Am Coll Cardiol. 2016 Dec 27;68(25):2733-2744. doi: 10.1016/j.jacc.2016.10.041.
4
Prevalence and Outcomes of Mitral Stenosis in Patients Undergoing Transcatheter Aortic Valve Replacement: Findings From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry.经导管主动脉瓣置换术患者二尖瓣狭窄的患病率和结局：来自胸外科医师学会/美国心脏病学会经导管瓣膜治疗登记处的研究结果。
JACC Cardiovasc Interv. 2018 Apr 9;11(7):693-702. doi: 10.1016/j.jcin.2018.01.245.
5
Updated clinical indications for transcatheter aortic valve implantation in patients with severe aortic stenosis: expert opinion of the Italian Society of Cardiology and GISE.经导管主动脉瓣植入术治疗严重主动脉瓣狭窄患者的更新临床适应证：意大利心脏病学会和 GISE 的专家意见。
J Cardiovasc Med (Hagerstown). 2018 May;19(5):197-210. doi: 10.2459/JCM.0000000000000636.
6
Transcarotid transcatheter aortic valve implantation.经颈动脉经导管主动脉瓣植入术。
Multimed Man Cardiothorac Surg. 2016 Apr 14;2016. doi: 10.1093/mmcts/mmw005. Print 2016.
7
Predicting Mortality After Transcatheter Aortic Valve Replacement: External Validation of the Transcatheter Valve Therapy Registry Model.经导管主动脉瓣置换术后死亡率预测：经导管瓣膜治疗登记模型的外部验证。
Circ Cardiovasc Interv. 2017 Nov;10(11). doi: 10.1161/CIRCINTERVENTIONS.117.005481.
8
Use of Society of Thoracic Surgeons Risk Models in the Assessment of Patients Who Underwent a Transcatheter Aortic Valve Replacement.胸外科医师协会风险模型在经导管主动脉瓣置换术患者评估中的应用
JAMA Cardiol. 2017 Apr 1;2(4):456-457. doi: 10.1001/jamacardio.2016.4133.
9
Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study.新型自膨式生物瓣经导管主动脉瓣置换术治疗重度主动脉瓣狭窄且不适合手术患者的早期临床转归：Evolut R 美国研究结果。
JACC Cardiovasc Interv. 2017 Feb 13;10(3):268-275. doi: 10.1016/j.jcin.2016.08.050.
10
Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术。
Curr Atheroscler Rep. 2016 May;18(5):27. doi: 10.1007/s11883-016-0577-2.
引用本文的文献
1
Machine-learning versus traditional methods for prediction of all-cause mortality after transcatheter aortic valve implantation: a systematic review and meta-analysis.机器学习与传统方法预测经导管主动脉瓣植入术后全因死亡率的比较：一项系统评价和荟萃分析。
Open Heart. 2025 Jan 21;12(1):e002779. doi: 10.1136/openhrt-2024-002779.
2
Comparison of outcomes after transcatheter aortic valve implantation following home versus non-home discharge.经导管主动脉瓣植入术后家庭出院与非家庭出院的结局比较。
Proc (Bayl Univ Med Cent). 2022 May 16;35(4):428-433. doi: 10.1080/08998280.2022.2064581. eCollection 2022.
3
Applicability of Transcatheter Aortic Valve Replacement Trials to Real-World Clinical Practice: Findings From EXTEND-CoreValve.经导管主动脉瓣置换术试验在真实世界临床实践中的适用性：EXTEND-CoreValve 研究结果。
JACC Cardiovasc Interv. 2021 Oct 11;14(19):2112-2123. doi: 10.1016/j.jcin.2021.08.006.
4
Perioperative risk assessment with Euroscore and Euroscore II in patients with coronary artery or valvular disease.使用欧洲心脏手术风险评估系统（Euroscore）和欧洲心脏手术风险评估系统二代（Euroscore II）对冠状动脉疾病或瓣膜疾病患者进行围手术期风险评估。
Medicine (Baltimore). 2018 Dec;97(50):e13572. doi: 10.1097/MD.0000000000013572.
5
Unmet issues in transcatheter aortic valve implantation.经导管主动脉瓣植入术中尚未解决的问题。
J Thorac Dis. 2018 Nov;10(Suppl 30):S3557-S3359. doi: 10.21037/jtd.2018.10.13.
6
Transcatheter Aortic Valve Replacement in Intermediate- and Low-Risk Patients.中低风险患者的经导管主动脉瓣置换术
J Am Heart Assoc. 2018 May 12;7(10):e007147. doi: 10.1161/JAHA.117.007147.
本文引用的文献
1
Predicting Early and Late Mortality After Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后早期和晚期死亡率预测。
J Am Coll Cardiol. 2016 Jul 26;68(4):343-52. doi: 10.1016/j.jacc.2016.04.057.
2
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement.一种简单的风险工具（OBSERVANT 评分），用于预测经导管主动脉瓣置换术后 30 天的死亡率。
Am J Cardiol. 2014 Jun 1;113(11):1851-8. doi: 10.1016/j.amjcard.2014.03.014. Epub 2014 Mar 18.
3
The multiparametric FRANCE-2 risk score: one step further in improving the clinical decision-making process in transcatheter aortic valve implantation.多参数法国-2风险评分：在改善经导管主动脉瓣植入临床决策过程方面更进一步。
Heart. 2014 Jul;100(13):993-5. doi: 10.1136/heartjnl-2014-305806. Epub 2014 Apr 23.
4
Outcomes following transcatheter aortic valve replacement in the United States.美国经导管主动脉瓣置换术后的结果。
JAMA. 2013 Nov 20;310(19):2069-77. doi: 10.1001/jama.2013.282043.
Zotero 插件